O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/2/2020ACC: 0001209191-20-053050
Officer· Chief Medical Officer
Since Jun 2018
+164.00
Net shares
Net buyer
$936.44
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
164.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+82.00
Price / share
$11.42
Trade value
$936.44
% of position
3.6%
9/30/2020
2.30K→2.38K
Total
Net shares
+82.00
Net value
$936.44
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2020 | A · Award | +82.00 | $11.42 | $936.44 | 3.6% | 2.30K | 2.38K |
| Total | +82.00 | $936.44 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
82.00 shares
Shares
+82.00
Strike price
13.43
Held after
82.00
Exercisable
—
9/30/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock82.00 shares | 9/30/2020 | A · Award | +82.00 | 13.43 | — | 82.00 |